...
首页> 外文期刊>Journal of Endodontics: Official Journal of American Association of Endodontists >Effect of Calcium Hydroxide Alone or in Combination with Ibuprofen and Ciprofloxacin on Nuclear Factor Kappa B Ligand and Osteoprotegerin Level in Periapical Lesions: A Randomized Controlled Clinical Study
【24h】

Effect of Calcium Hydroxide Alone or in Combination with Ibuprofen and Ciprofloxacin on Nuclear Factor Kappa B Ligand and Osteoprotegerin Level in Periapical Lesions: A Randomized Controlled Clinical Study

机译:单独的氢氧化钙或与西普洛芬和环丙沙星组合的影响核因子Kappa B配体和骨髓病变中的骨髓病变:随机对照临床研究

获取原文
获取原文并翻译 | 示例

摘要

Introduction: The aim of the present study was to evaluate the effects of calcium hydroxide (Ca[OH](2)), Ca(OH)(2) + ibuprofen, and Ca(OH)(2) + ciprofloxacin in terms of receptor activator of nuclear factor kappa B ligand (RANKL) and osteoprotegerin (OPG) levels in asymptomatic periapical lesions. Methods: Sixty-six patients were randomly divided into 3 groups using a Web program according to the medication selected: Ca(OH)(2), Ca(OH)(2) + ibuprofen, and Ca(OH)(2) + ciprofloxacin. After removing gutta-percha from the root canals, the RANKL and OPG samples were taken from the interstitial fluid of the apical tissues using 3 paper points. At the second appointment, medicaments were removed, and second sampling was performed using the same method. The RANKL and OPG levels were measured by the enzyme-linked immunosorbent assay, and the RANKL/OPG ratio was calculated. Results: According to the intragroup analysis, there were no statistically significant differences between the preoperative and postoperative levels of the RANKL/OPG ratio in any of the groups. Intergroup analyses showed that there were no statistically significant differences among the Ca(OH)(2), Ca(OH)(2) + ibuprofen, Ca(OH)(2) + ciprofloxacin groups in terms of the percentage change in RANKL/OPG levels before and after treatment. Conclusions: Within the limitations of the present study, it can be concluded that addition of ibuprofen or ciprofloxacin to Ca(OH)(2) paste does not provide any extra benefit in terms of lowering RANKL and OPG levels.
机译:介绍:本研究的目的是评估氢氧化钙(Ca [OH](2)),Ca(OH)(2)+布洛芬和Ca(OH)(2)+ CiProfloxacin的作用在受体方面核因子Kappa B配体(RANKL)和骨盆蛋白(OPG)水平的核因子Kappa B配体(RANKL)和骨盆蛋白(OPG)水平。方法:66例患者根据选定的药物随机分为3组:Ca(OH)(2),Ca(OH)(2)+布洛芬和Ca(OH)(2)+环丙沙星(2)+ Ciprofloxacin 。在从根部管中除去牙齿曲面后,使用3个纸点从顶端组织的间质液中取出RANK1和OPG样品。在第二次预约时,除去药物,使用相同的方法进行第二取样。通过酶联免疫吸附测定法测量RANK1和OPG水平,并计算RANKL / OPG比率。结果:根据Intractous分析,在任何组中术前和术后水平的术前和术后水平没有统计学显着差异。依法组分析表明,Ca(OH)(2),Ca(2)+布洛芬,Ca(OH)(2)+环丙沙星在RankL / OPG的百分比变化方面没有统计学显着差异治疗前后的水平。结论:在本研究的局限内,可以得出结论,加入布洛芬或环丙沙星至Ca(OH)(2)浆不会在降低RANKL和OPG水平方面提供任何额外的益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号